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Summary Although photodynamic therapy (PDT) has shown great promise for the inactivation of
Candida species, its effectiveness against azole-resistant pathogens remains poorly
documented. This in vitro study describes the association of Photogem (Photogem,
Moscow, Russia) with LED (light emitting diode) light for the photoinactivation of
fluconazole-resistant (FR) and American Type Culture Collection (ATCC) strains of
Candida albicansandCandida glabrata. Suspensions of eachCandida strainwere treatedwith
five Photogem concentrations and exposed to four LED light fluences (14, 24, 34 or
50 min of illumination). After incubation (48 h at 37 C), colonies were counted
(CFU ml)1). Single-species biofilmswere generated on cellulosemembrane filters, treated
with 25.0 mg l)1 of Photogem and illuminated at 37.5 J cm)2. The biofilms were then
disrupted and the viable yeast cells present were determined. Planktonic suspensions of
FR strainswere effectively killed after PDT. Itwasobserved that the fungicidal effect of PDT
was strain-dependent. Significant decreases in biofilm viability were observed for three
strains of C. albicans and for two strains of C. glabrata. The results of this investigation
demonstrated that although PDT was effective against Candida species, fluconazole-
resistant strains showed reduced sensitivity to PDT. Moreover, single-species biofilms
were less susceptible to PDT than their planktonic counterparts.
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Introduction
Oral candidiasis is a common opportunistic infection of
the oral cavity caused by Candida species, the common-
est being Candida albicans.1,2 Recently, infections with
species other than C. albicans, notably C. glabrata, have
been increasingly described.3 Numerous predisposing
factors for oral candidiasis have been recognised.1,2,4,5
Alterations in immune status associated with the AIDS
epidemic, cancer chemotherapy, and organ and bone
marrow transplantation has been often related to the
increase in the incidence of Candida infections.1,4 In
addition, the use of dental prosthesis and subsequent
biofilm formation on epithelial surfaces and prosthetic
devices is critical in the development of denture-associ-
ated candidiasis, which is a frequent condition occur-
ring in denture wearers.5 Considering the high
frequency of Candida infections in immunocompromised
patients, it is clear that effective antifungal therapy is
necessary. Topical antifungal agents are often pre-
scribed to manage oral candidiasis.6,7 However, these
agents achieve only a transient response and relapses
are frequent.8,9 As the recurrence rate is high, systemic
azole antifungals (e.g. fluconazole, itraconazole) have
been largely used for the treatment of fungal infec-
tions.8,10,11 Nevertheless, the increased use of azoles,
combined with several cases of treatment failures, has
drawn attention to the problem of antifungal drug
resistance.12–14
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Diagnosis,Therapy and Prophylaxis of Fungal Diseases
Clinical resistance to antifungal drugs is a broad
concept describing failure of an antifungal therapy,
which results in persistence or progression of an
infection.14,15 An organism that is resistant to a drug
prior to exposure is described as having primary or
intrinsic resistance. Secondary resistance develops in
response to exposure to an antimicrobial agent over
long periods.14 It has been already demonstrated that
exposure to fluconazole provided resistance in the
C. albicans population of HIV-positive patients13 and
also led to the replacement of fluconazole-susceptible
C. albicans strains with other species that are intrinsi-
cally less fluconazole sensitive, such as C. glabrata and
C. krusei.13,14 The fungistatic activity of the azoles has
also been associated with the failure of antifungal
therapy in immunocompromised patients. For these
agents, host defences are important contributors to the
cure of the infection.16,17 Another aspect related to
antifungal resistance and recurrence of infection is the
ability of Candida spp. to form biofilms on surfaces.14,18
A biofilm has been defined as a community of micro-
organisms organised at interfaces, enclosed in a self-
produced polymeric matrix and adhered to an inert or
living tissue.19 The presence of an exopolymeric matrix
couple with the organisation of layers of cells may
confer protection on organisms in the inner layers
contributing to antifungal resistance.18
To overcome the problems associated with antifungal
resistance, photodynamic therapy (PDT) has been
evaluated as a promising method of treatment of oral
candidiasis.20–23 PDT involves the use of a photosensitis-
ing compound and a light source.22,24 After the target
cells were treated with the photosensitiser (PS), irradia-
tion with non-thermal visible light of a suitable
wavelength (the maximum absorption of the PS), in the
presence of oxygen, would excite PS to initiate chemical
reactions. The production of free radicals and other
reactive oxygen species, such as singlet oxygen, leads to
cellular damage, membrane lyses and protein inactiva-
tion.24,25 Notably, the mechanism of PDT inactivation of
fungi is completely different from that of antifungal
agents. The reactive oxygen species promote perforation
of the cell wall and membrane, thereby permitting the PS
to translocate into the cell. Once inside the cell, oxidising
species generated by light excitation induces photo-
damage to internal cell organelles and cell death.25,26
Although a number of studies have shown the
susceptibility of Candida species to PDT,20,21,26,27 there
are still some aspects that remain to be better elucidated
in vitro. Because of the non-specific oxidising agents,
organisms resistant to conventional antifungal agents
could be successfully killed by PDT and the development
of resistance to such therapy (secondary resistance)
seems to be unlikely. It has been already shown that
repeated photosensitisation does not induce resistance
in microorganisms.28 Nevertheless, some studies have
demonstrated that drug-resistant strains are less vul-
nerable to PDT than drug-susceptible organisms.17,29
There are only a few reports available regarding the
susceptibility of fluconazole-resistant C. albicans strains
to PDT.17,23 Considering that the most promising
advantage of PDT would be the treatment of infections
resistant to antifungal agents, the susceptibility of
resistant Candida species to PDT should be better
documented. The purpose of this study was to evaluate
the efficacy of PDT in killing fluconazole-resistant (FR)
strains of C. albicans and C. glabrata. The investigation
was designed to find the minimal PS concentration and
light fluence for the complete inactivation of the strains
in the planktonic mode. Then, the most promising
combination of PS and light were evaluated against
single-species biofilms of C. albicans and C. glabrata.
Materials and methods
Photosensitiser and light source
Photogem (Limited Liability Company Photogem,
Moscow, Russia) was used as PS as it has regulatory
approval for clinical use and it has been largely used in
cancer phototherapy. This PS is a haematoporphyrin
derivative (HpD) produced in Russia, very similar to
Photofrin II. The two PSs present similar molecular
structure as well as the ratio between monomer and
oligomers in the lyophilised powder form.30 Stock
solutions of Photogem were prepared by dissolving
the powder in sterile saline and kept in the dark until
use. Photogem was excited by an LED (light emitting
diode) light in the blue region of the spectrum, which PS
absorbs more efficiently than red light (Fig. 1).
A LED device, named Bio Table, was designed
by Instituto de Fı´sica de Sa˜o Carlos (University of Sa˜o
Paulo, Sa˜o Carlos, SP, Brazil). This system is composed
of eight royal blue LEDs (LXHL-PR09, Luxeon III
Emitter; Lumileds Lighting, San Jose, CA, USA) uni-
formly distributed throughout the device. The LED
device covered the wavelength range from 440 to
460 nm, with maximum emission at 455 nm.
The intensity of light delivered was 12.5 mW cm)2.
The fluences tested were 10.5; 18.0; 25.5 or
37.5 J cm)2. To achieve those fluences, the exposure
time was calculated with the dosimetry formula:
Fluence (J cm)2) = Intensity of light (W cm)2) · expo-
sure time (s).
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Fungal strains
Six FR clinical patient isolates were used in this study
(C. albicans: 10R, 15R, 23R; C. glabrata: 50R, 63R,
87R). In addition, American Type Culture Collection
strains (ATCC; Rockville, MD, USA) of C. albicans (ATCC
90028) and C. glabrata (ATCC 2001) were included as
reference strains (Table 1). The minimum inhibitory
concentration (MIC) for each strain was determined
using the broth microdilution reference method31 for
fluconazole sensitivity. Isolates were maintained in solid
yeast-peptone-glucose medium and frozen at )70 C.
Photodynamic treatment against planktonic cultures
The yeast were individually inoculated in 5 ml of tryptic
soy broth (TSB) and grown aerobically overnight at
37 C. Each culture was centrifuged at 2000 rpm for
10 min, and the pellet washed twice with sterile distilled
water and resuspended in sterile saline to a turbidity
106 cells ml)1 (McFarland standard). Aliquots of
100 ll of each Candida standardised suspension were
individually transferred to separate wells of a 96-well
microtitre plates. An equal volume of PS solutions was
added to each well to give final concentrations of 2.5,
5.0, 10.0, 25.0 and 50.0 mg l)1. After incubation in
the dark for 30 min (pre-irradiation time), each plate
was placed on the LED device. Illumination was
performed for 14, 24, 34 or 50 min, resulting in a
total fluence of 10.5, 18.0, 25.5 or 37.5 J cm)2
respectively (P+L+). To determine whether PS alone
had any effect on cell viability, additional wells con-
taining the yeast suspensions were exposed to PS under
identical conditions to those described above, but not to
LED light (P+L)). The effect of LED light alone was
determined by exposing cells to light without being
previously exposed to PS (P)L+). Suspensions exposed
to neither PS nor LED light acted as overall control
(P)L)). To determine the cell survival, aliquots of the
contents of each well were serially diluted 10-fold in
sterile saline. Triplicate 25 ll aliquots were spread over
the surfaces of Sabouraud dextrose agar (SDA) plates
containing 5 mg l)1 gentamicin. All the plates were
aerobically incubated at 37 C for 48 h.
Based on the experiments described above, the most
effective PS concentration and light fluence were
selected and their long-term fungicidal effect against
the yeast suspensions was determined. The experimen-
tal protocol was carried out as outlined above except
that aliquots of the yeast suspensions were transferred
to TSB tubes immediately after PDT procedures and
incubated at 37 C for further 7 days. Cultures were
interpreted as positive or negative growth.
Photodynamic treatment against Candida biofilms
Yeast isolates were individually incubated overnight at
37 C in TSB and diluted in fresh medium to a turbidity
106 cells ml)1 (McFarland standard). Aliquots of the
standardised cultures were transferred to the surface of
cellulose nitrate membrane filters (0.2 lm pore size,
13 mm diameter – Sartorius Stedim Biotech S.A,
Germany) to generate single-species biofilms. Briefly,
the membranes were placed on the surface of SDA,
inoculated with the standardised cultures and incu-
bated aerobically for 48 h at 37 C. Following incuba-
tion, the membrane filters were removed aseptically
from the agar plate and transferred slowly, so as to
avoid any disruption of the biofilm, into separate wells
of a 24-well microtitre plates containing 500 ll of
Photogem solution at 25 mg l)1. After incubation in
the dark (30 min; pre-irradiation time), the plates were
placed on the LED device and illuminated for 50 min
(37.5 J cm)2). Control membranes were exposed to
Table 1 Original source of clinical isolates and ATCC strains.
Strains identification Species Original source
10R Candida albicans Esophagus
15R C. albicans Oropharynx
23R C. albicans Oral infection
ATCC 90028 C. albicans Blood
50R Candida glabrata Urine
63R C. glabrata Urine
87R C. glabrata Urine
ATCC 2001 C. glabrata Faeces
Figure 1 Emission spectrum of the blue and red LED (light
emitting diode) light and the absorbance spectrum of Photogem
at concentration of 50 mg l)1.
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neither PS nor LED light. The membrane filters were
then carefully transferred into 5 ml of sterile saline and
vortexed for 1 min to resuspend the cells from the
biofilms. Ten-fold serial dilutions were generated from
the fungal suspensions and plated on SDA in triplicate.
The plates were then aerobically incubated at 37 C for
4 days.
After incubation, yeast colony counts of each plate
were quantified using a digital colony counter (CP 600
Plus, Phoenix Ind Com Equipamentos Cientı´ficos Ltda,
Araraquara, SP, Brazil). The colony forming unit per
millilitre (CFU ml)1) was determined.
Statistical analysis
Each experimental treatment with the PS concentra-
tions in the presence of the mentioned light fluences was
repeated three times. For the purposes of analysis,
CFU ml)1 values were transformed into logarithm
values (log10). For the planktonic culture results,
comparisons between two logarithms were performed
using the unpaired Students t-test. The results of PDT
against biofilms were evaluated using the analysis of
variance (ANOVA) and Tukey Honestly Significant Differ-
ence (HSD) post hoc test. Differences were considered
statistically significant at P < 0.05.
Results
The results of MIC studies on Candida strains confirmed
that the clinical isolates of C. albicans and C. glabrata
were resistant to fluconazole, while the ATCC strains
were susceptible to this drug. The MIC values found for
C. albicans strains were >64, 16, >64 and 1 lg ml)1 for
10R, 15R, 23R and ATCC 90028 respectively. For
C. glabrata strains, the MIC values established were >64,
16, 641 and <8 lg ml)1 for 50R, 63R, 87R and ATCC
2001 respectively.
According to the results obtained with planktonic
cultures, the association of specific Photogem concen-
trations and blue LED light fluences resulted in inacti-
vation of FR and ATCC strains. The inactivation
(complete killing) was accepted when no evidence of
growth on plates was observed after 48 h at 37 C.
Complete killing of the three FR C. albicans strains was
achieved with 50.0 mg l)1 of PS associated with illumi-
nation at 18.0 J cm)2. Inactivation of FR C. albicans
with lower PS concentrations was verified by increasing
the light fluence to 25.5 and 37.5 J cm)2 (Fig. 2a). In
comparison with the ATCC strain (Fig. 2b), FR C. albi-
cans required higher PS concentrations to inactivate it at
25.5 and 37.5 J cm)2 (P < 0.05). The mean CFU ml)1
values obtained from PDT against the three FR C. glabrata
are illustrated in Fig. 3a. Complete killing of the FR
strains of this species was observed with 25.0 mg l)1 of
PS, after illumination at both 25.5 and 37.5 J cm)2. At
fluence of 37.5 J cm)2, C. glabrata ATCC was killed with
a lower PS concentration than that required for FR
strains (Fig. 3b). In summary, the association of
25.0 mg l)1 with 37.5 J cm)2 resulted in complete
inactivation of all microorganisms, irrespective of the
species and strain evaluated.
The inactivation of each fluconazole-resistant strain
was also evaluated separately. It can be seen from
Table 2 that the PS concentration required for photoin-
activation of each of the C. albicans FR strains was
different at 18.0 and 25.5 J cm)2, while the PS
concentration for killing each of the C. glabrata FR
strains differed only at 18.0 J cm)2. However, high light
fluences led to a homogeneous pattern of photoinacti-
vation among the three FR strains of the same species.
The long-term fungicidal effect against the yeast
suspensions was confirmed after 7 days of incubation
at 37 C. For all strains tested, the association of
25 mg l)1 with 37.5 J cm)2 resulted not only in the
absence of colonies on plates but also in the negative
growth in the TSB tubes, which indicated that no
revival occurred after PDT. In addition, exposure to LED
light alone or Photogem alone had no effect on the
viability of all strains evaluated. No significant varia-
tions in CFU ml)1 among P+L), P)L+ and P)L)
conditions were observed.
Figure 2 Graphic representation of the
effect of PS concentration and light fluence
on Candida albicans viability. (a) Mean
values and standard deviation from loga-
rithmic of survival counts (CFU ml)1) of
the three fluconazole-resistant C. albicans;
(b) values from logarithmic of survival
counts (CFU ml)1) of ATCC C. albicans.
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It can be seen from Fig. 4 that PDT reduced the
viability of C. albicans and C. glabrata biofilms when
membranes were exposed to 25 mg l)1 of PS and
illuminated at 37.5 J cm)2 (P+L+). Significant
decreases in viable counts were observed for C. albicans
ATCC, 10R and 23R (P < 0.05), and for C. glabrata
ATCC and 50R (P < 0.05). Nevertheless, the reduction
in viable counts was smaller than 1 log10-unit in all
experiments. Positive control biofilms showed substan-
tial microbial growth on plates after incubation. There
were no significant differences in the log10-unit among
the biofilms generated with the reference strains and
clinical isolates belonging to the same species. However,
the mean number of log10-unit for C. glabrata was
significantly higher than those observed for C. albicans.
Discussion
One of the most promising aspects of PDT is that
organisms resistant to conventional antifungal agents
could be killed by the oxidising species generated by
light excitation.20,23,32 In the present study, PDT was
effective in inactivating planktonic suspensions of the
three FR clinical isolates of C. albicans and C. glabrata,
using Photogem with LED light. This finding agreed
with published studies in which substantial killing of
azole-resistant strains of C. albicans17,23,32 and C. glab-
rata32 was achieved with the use of toluidine blue,17
methylene blue23 and cationic porphyrin32 as PS. An
important observation, however, was that FR strains
had different responses to PDT from those of the ATCC
strains. At 37.5 J cm)2, higher concentrations of
Photogem were required to achieve the photoinacti-
vation of the FR Candida species in comparison with the
ATCC strains. Similar results were reported by Jackson
et al. [17], who observed that PDT was less efficient in
killing azole-resistant strains of C. albicans. Reduced
sensitivity of resistant pathogens to PDT seems to occur
not only for Candida species, but also for some bacte-
rial strains, such as methicillin-resistant strains of
Figure 3 Graphic representation of the
effect of PS concentration and light fluence
on Candida glabrata viability. (a) Mean
values and standard deviation from loga-
rithmic of survival counts (CFU ml)1) of
the three fluconazole-resistant C. glabrata;
(b) values from logarithmic of survival
counts (CFU ml)1) of ATCC C. glabrata.
Table 2 Minimal Photogem concentration (mg l)1) for the
photoinactivation of all Candida strains.
Light fluence (J cm)2)
Minimal lethal concentration (mg l)1)
Candida albicans C. glabrata
ATCC 10R 15R 23R ATCC 50R 63R 87R
10.5 –1 –1 –1 –1 –1 –1 –1 –1
18 50 50 10 10 –1 –1 50 –1
25.5 5 5 10 10 –1 25 25 25
37.5 2.5 5 5 5 10 25 25 25
1Complete inactivation was not observed.
Figure 4 Graphic representation of the
mean values and standard deviation from
logarithmic of survival counts (CFU ml)1)
of Candida albicans (a) and Candida glabrata
(b) biofilms. P+L+ represents the biofilms
treated with 25 mg l)1 of Photogem and
irradiated at 37.5 J cm)2; P)L) represents
control biofilms. Asterisks (*) represents
significant differences from control (P)L)).
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Staphylococcus aureus.29,33 Thus, it is possible that
mechanisms of resistance to traditional drugs can
interfere in PDT effectiveness. Some investigations have
suggested that azole resistance can be associated with
point mutations and overexpression of the Erg11 gene,
resulting in alterations in membrane lipid fluidity.14 It
was also reported that in vitro deletion of the Erg11 gene
of FR C. glabrata strains allowed the organisms to
become extremely susceptible to oxidative killing.34 As
PDT mediated by porphyrins initially target the plasma
membrane, alterations in this organelle can possibly
influence the effectiveness of PDT. Therefore, it can be
suggested that the modifications associated with Erg11
overexpression might affect the sensitivity to PDT.
However, further investigations should be conducted
to test the effectiveness of PDT against isogenic mutants
in which the Erg11 has been disrupted.
Because the association of 25.0 mg l)1 of Photogem
with 37.5 J cm)2 of blue LED light (50 min of illumi-
nation) resulted in inactivation of all cell suspensions,
these parameters were selected to be tested against
single-species biofilms. The in vitro model adopted for
biofilm formation was based on the methodology
described by Spratt et al. [35], and it has been success-
fully applied in several investigations on antimicrobial
agents.35–37 Control membranes contaminated with
C. albicans and C. glabrata strains produced substantial
microbial growth on plates after 4 days of incubation.
The mean colony count (log10 CFU ml
)1) for C. glabrata
biofilms was significantly higher than that observed for
C. albicans. There have been frequent reports of the
superior adherence of C. glabrata to different sur-
faces38,39 and this can be attributed to its smaller size
and higher hydrophobicity, compared with C. albi-
cans.38 When biofilms were exposed to 25.0 mg l)1 of
Photogem with 37.5 J cm)2 of blue LED light (50 min
of illumination), significant reduction in cell viability
was observed. However, the reduction rates were less
than 1 log (Table 3), suggesting that the organisms
grown on biofilms may have reduced sensitivity to
photodynamic damage. This finding may be explained
due to structural differences between planktonic and
biofilm-grown cells.18,40,41 Donnelly et al. [22] recom-
mended longer application times of PS to obtain PDT
response when biofilms were implicated. In addition,
Chabrier-Rosello´ et al. [32] reported the use of higher
Photofrin (Wyeth-Ayerst Lederle Inc., Dublin, Ireland)
concentrations to compensate the increased organism
biomass of C. albicans biofilms in comparison with germ
tubes. Accordingly, high concentrations of methylene
blue (450 and 500 mg l)1) were used in association
with 275 J cm)1 to eradicate completely C. albicans
from induced infection of mouse tongues.23 Neverthe-
less, the occurrence of cytotoxic effects on healthy cells
should be considered before clinical application of such
high PS concentrations. The results of the present study
showed no dark toxicity of Photogem against C. albi-
cans and C. glabrata cells. In addition, in vivo investiga-
tions have observed no adverse effects of the dyes,
toluidine blue and methylene blue, on periodontal42 and
mucosal23 structures, in spite of using high dye
concentrations. On the other hand, substantial damage
to fibroblasts has been reported when high concentra-
tions of a cationic porphyrin were used.43 Thus, further
in vivo investigations are necessary to evaluate the
cytotoxic potential of haematoporphyrin derivatives
before clinical applications of antimicrobial PDT.
Animal models of oral candidiasis could be an alterna-
tive to verify whether the surrounding tissue and
normal microbial flora will not be damaged after PDT
mediated by high porphyin concentrations.
Finally, it is important to emphasise that investiga-
tions concerning the use of PDT against Candida are
usually performed with the use of one reference
strain21,44–46 or one clinical isolate.23 We evaluated
the effect of PDT against four C. albicans and four
C. glabrata strains and observed that response of strains
to PDT was not homogenous among the three FR
strains of the same species. This result agreed with those
of Lambrechts et al. [47] who reported some significant
variation in the sensitivity to PDT of three wild-type
strains of C. albicans. In the present investigation, single-
species biofilms of each FR microorganism showed
different responses to PDT. The variation among FR
strains of the same species in the manner in which they
responded to PDT may have important clinical rele-
vance. It indicates the importance of investigating more
than one isolate belonging to a single species, before
drawing conclusions with regard to the inter-species
differences in susceptibility to PDT. The present inves-
Table 3 Log reduction rates obtained after PDT (25 mg l)1 of
Photogem and 37.5 J cm)2 of light) against planktonic and biofilm
cultures.
Strains
Culture
Planktonic Biofilm
10R 6.65 0.34
15R 6.66 0.15
23R 6.63 0.23
ATCC 90028 6.66 0.23
50R 6.76 0.20
63R 6.72 0.14
87R 6.75 0.13
ATCC 2001 6.72 0.19
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tigation also found that C. glabrata strains were less
susceptible to PDT when compared with C. albicans. In
agreement, Bliss et al. [20] performed PDT with Photo-
frin concentrations ranging from 10 to 0.01 mg l)1
and illumination with Hg arc lamp against C. glabrata
and C. albicans. The authors noticed that the former
species showed less sensitivity to photoinactivation. One
possible explanation is the phenomenon of co-adhesion
between closely apposed blastoconidia reported by Luo
and Samaranayake [38], which may limit the contact
area between the C. glabrata cells and the PS.
Although some studies have shown the fungicidal
effect of laser light without a photosensitiser,48,49 the
results of the present investigations disagree with these
findings, because LED light alone does not result in
toxicity to yeast cells. In addition, the use of Photogem
alone did not induce toxicity in the strains evaluated.
Thus, the killing rates observed in this study were due to
the photodynamic effect. In conclusion, the results of this
investigation demonstrated that FR C. albicans and
C. glabrata may present reduced sensitivity to PDT, in
comparison with reference strains. Microorganisms
organised in biofilms appeared to be less susceptible to
photoinactivation when compared with planktonic cells.
Furthermore, it seems that there may be an inter-strain
variation in the susceptibility to PDT. Considering the
results presented, in vitro investigations of PDT against
FR strains are indispensable steps before conducting
in vivo evaluations. However, in vivo conditions were not
simulated in this investigation and the parameters used
may be not adequate in a clinical situation.
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